| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Crispr Therapeutics AG (CRSP) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 18 sells. CRSP is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 255.5K | $13.89M | - | |
| Dir | 22.0K | $1.20M | - | |
| CFO | 19.5K | $1.06M | - | |
| Other | 19.4K | $1.05M | -3,786 | |
| Other | 17.0K | $924.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 12, 2017 | Emster Kurt Von62 | Director | Sell | 31,992 | $16.56 | $529,937.60 | -0.7% | |
| Jul 5, 2017 | Emster Kurt Von62 | Director | Sell | 4,254 | $16.26 | $69,170.04 | -0.2% | |
| Jun 29, 2017 | Emster Kurt Von62 | Director | Sell | 43,202 | $16.90 | $730,124.88 | -0.9% | |
| Jun 27, 2017 | Emster Kurt Von62 | Director | Sell | 81,435 | $17.08 | $1,390,611.45 | -1.6% | |
| Jun 23, 2017 | Emster Kurt Von62 | Director | Sell | 32,368 | $16.23 | $525,302.10 | -0.6% | |
| Jun 22, 2017 | Novak Rodger75 | Chief Executive Officer | Sale+OE | 10,825 | $15.37 | $166,387.83 | -0.9% | |
| Jun 21, 2017 | Novak Rodger75 | Chief Executive Officer | Sale+OE | 30,222 | $15.01 | $453,510.86 | -0.8% | |
| Jun 9, 2017 | Novak Rodger75 | Chief Executive Officer | Sale+OE | 5,303 | $15.02 | $79,628.05 | -0.2% | |
| May 30, 2017 | Novak Rodger75 | Chief Executive Officer | Sale+OE | 3,650 | $15.02 | $54,828.84 | -0.3% | |
| May 17, 2017 | Novak Rodger75 | Chief Executive Officer | Sale+OE | 50,000 | $16.26 | $812,859.34 | -2.0% |